 |
|
|
|
|
Green plants are the lowest cost source of proteins, and proteins made in green plants are free of animal pathogens. FhCMB has access to a set of plant science-based technologies that create a platform for the rapid, safe and low-cost production of proteins in plants. This platform is often called Molecular Farming, and it can be used to produce new vaccines, make low-cost industrial enzymes, or manufacture therapeutic proteins, such as monoclonal antibodies, cytokines, lymphokines or peptide hormones. There are two major routes for achieving Molecular Farming: 1) permanently modifying the plant genome, thus creating a transgenic plant, and 2) transient gene expression, in which RNA vectors are introduced to modify a plant's protein synthesis in a way that is not inherited. In general, the transient approach gives higher yields of the desired protein compared to the transgenic plant approach.
|
|
|
|
